SCHEMBL13507635

SCHEMBL13507635

Cn1c2cc(-c3ccc(-c4ccc5ccccc5c4)cc3)ccc2c2c3ccccc3c3c4ccc(-c5cccc6ccccc56)cc4n(C)c3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.41
▸ LIMK1 P53667 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ HSD11B1 P28845 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ALK Q9UM73 1/20 0.37
▸ FLT3 P36888 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507630 0.97 CA12 (0.40) METLIMK1MAOBPIM1CA12
SCHEMBL13508170 0.94 CA12 (0.43) LIMK1MAOBCA12CA1CA2
SCHEMBL13507467 0.92 KDM4E (0.40) LIMK1MAOBCA12CA1CA2
SCHEMBL13507850 0.91 LIMK1 (0.46) LIMK1MAOBCA1CA2CA9
SCHEMBL13506862 0.90 MET (0.38) METMAOBPIM1CA12CA1
SCHEMBL13507734 0.89 LIMK1 (0.44) LIMK1MAOBHSD11B1CYP11B1CYP11B2
SCHEMBL13507633 0.88 MAOB (0.50) LIMK1MAOBHSD11B1CYP1A2CYP11B1
SCHEMBL13507846 0.85 LIMK1 (0.41) LIMK1MAOBHSD11B1CYP11B1CYP11B2
SCHEMBL13507607 0.83 CA12 (0.43) MAOBCA12CA1CA2CA9
SCHEMBL13508164 0.83 LIMK1 (0.39) LIMK1MAOBHSD11B1HTR1DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 MET 4689/4885LIMK1 222/4885MAOB 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback